載入...
Novel therapeutics for recurrent cervical cancer: Moving towards personalized therapy
While screening programs and HPV vaccination have decreased the incidence of cervical cancer, still over 13,000 cases occur in the United States annually. Early stage cervical cancer has an excellent long-term prognosis, with 5-year survival for localized disease being >90%. Survival decreases ma...
Na minha lista:
| 發表在: | Drugs |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7033025/ https://ncbi.nlm.nih.gov/pubmed/31939072 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-019-01249-z |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|